Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
HTL Biotechnology’s first symposium at the congress was a resounding success. With a focus on collagen, DNA, and regenerative medicine, we had the opportunity to showcase our cutting-edge technologies, which participants found particularly innovative.
The connections established during the congress promise a bright future for these solutions and reflect growing interest in our expertise.
This first edition confirmed the importance of HTL Biotechnology’s presence at such a prominent event, paving the way for future collaborations and developments.
HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.
We are excited to share that HTL Biotechnology is present at the AMWC 2025 in Monaco.
On March 10 to 12, 2025, HTL Biotechnology was proud to be present at CIBE (China International Beauty Expo) in Guangzhou, reaffirming our commitment to the dermatology and beauty industries.